FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294281861> ?p ?o ?g. }

• W4294281861 abstract "Summary Subacute thyroiditis is an inflammatory disorder of the thyroid gland that has previously been described following viral illnesses and occasionally post vaccination such as influenza vaccine. 2021 was a revolutionary year for the development of SARS-CoV-2 vaccinations with multiple different vaccines now available. There are increasing numbers of case reports of thyroiditis following these vaccinations. We report a case of a 50-year-old female who developed subacute thyroiditis 6 days post ChAdOx1 nCoV-19 vaccine (AZD1222 produced by AstraZeneca Vaxzevria). The initial thyrotoxic phase was followed by overt hypothyroidism. This resolved spontaneously within 5 months without levothyroxine replacement. We hope that our case will add to the growing literature of cases of thyroiditis occurring after multiple different types of SARS-CoV-2 vaccination and create awareness of this rare but treatable adverse effect. We also review the literature on the proposed mechanisms behind this adverse effect. Learning points Subacute thyroiditis is an inflammatory disorder of the thyroid gland that can occur after a viral illness or vaccination against certain infections. Subacute thyroiditis is a rare adverse effect that has been reported to occur after different types of SARS-CoV-2 vaccinations. Subacute thyroiditis post vaccination is relatively straightforward to manage, with some patients requiring non-steroidal anti-inflammatory drugs and beta-blockers, while more severe cases may require corticosteroid therapy. This adverse effect should not dissuade vaccination use at a population level. There are many postulated mechanisms for the development of subacute thyroiditis following vaccination including the presence of the ACE-2 receptor for SARS-CoV-2 on the thyroid gland, an inflammatory/immune response as is seen in COVID-19 infection itself and molecular mimicry between SARS-CoV-2 spike protein and healthy thyroid antigen." @default.
• W4294281861 created "2022-09-02" @default.
• W4294281861 creator A5062413793 @default.
• W4294281861 creator A5079127996 @default.
• W4294281861 date "2022-09-01" @default.
• W4294281861 modified "2023-10-18" @default.
• W4294281861 title "Subacute thyroiditis post viral vector vaccine for COVID-19" @default.
• W4294281861 cites W1974811965 @default.
• W4294281861 cites W2048598350 @default.
• W4294281861 cites W2419175504 @default.
• W4294281861 cites W2510464317 @default.
• W4294281861 cites W3041983551 @default.
• W4294281861 cites W3120380827 @default.
• W4294281861 cites W3121259291 @default.
• W4294281861 cites W3138561593 @default.
• W4294281861 cites W3163457571 @default.
• W4294281861 cites W3164719154 @default.
• W4294281861 cites W3206751442 @default.
• W4294281861 cites W3216532396 @default.
• W4294281861 cites W4210395762 @default.
• W4294281861 cites W4210669519 @default.
• W4294281861 doi "https://doi.org/10.1530/edm-21-0193" @default.
• W4294281861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36053182" @default.
• W4294281861 hasPublicationYear "2022" @default.
• W4294281861 type Work @default.
• W4294281861 citedByCount "1" @default.
• W4294281861 countsByYear W42942818612023 @default.
• W4294281861 crossrefType "journal-article" @default.
• W4294281861 hasAuthorship W4294281861A5062413793 @default.
• W4294281861 hasAuthorship W4294281861A5079127996 @default.
• W4294281861 hasBestOaLocation W42942818611 @default.
• W4294281861 hasConcept C126322002 @default.
• W4294281861 hasConcept C187212893 @default.
• W4294281861 hasConcept C197934379 @default.
• W4294281861 hasConcept C203014093 @default.
• W4294281861 hasConcept C22070199 @default.
• W4294281861 hasConcept C2775883008 @default.
• W4294281861 hasConcept C2776216339 @default.
• W4294281861 hasConcept C2778696486 @default.
• W4294281861 hasConcept C526584372 @default.
• W4294281861 hasConcept C71924100 @default.
• W4294281861 hasConceptScore W4294281861C126322002 @default.
• W4294281861 hasConceptScore W4294281861C187212893 @default.
• W4294281861 hasConceptScore W4294281861C197934379 @default.
• W4294281861 hasConceptScore W4294281861C203014093 @default.
• W4294281861 hasConceptScore W4294281861C22070199 @default.
• W4294281861 hasConceptScore W4294281861C2775883008 @default.
• W4294281861 hasConceptScore W4294281861C2776216339 @default.
• W4294281861 hasConceptScore W4294281861C2778696486 @default.
• W4294281861 hasConceptScore W4294281861C526584372 @default.
• W4294281861 hasConceptScore W4294281861C71924100 @default.
• W4294281861 hasLocation W42942818611 @default.
• W4294281861 hasLocation W42942818612 @default.
• W4294281861 hasLocation W42942818613 @default.
• W4294281861 hasLocation W42942818614 @default.
• W4294281861 hasOpenAccess W4294281861 @default.
• W4294281861 hasPrimaryLocation W42942818611 @default.
• W4294281861 hasRelatedWork W1794581897 @default.
• W4294281861 hasRelatedWork W2000528211 @default.
• W4294281861 hasRelatedWork W2325709188 @default.
• W4294281861 hasRelatedWork W2351106485 @default.
• W4294281861 hasRelatedWork W2360924890 @default.
• W4294281861 hasRelatedWork W2380723515 @default.
• W4294281861 hasRelatedWork W2383290902 @default.
• W4294281861 hasRelatedWork W2776637331 @default.
• W4294281861 hasRelatedWork W3029058467 @default.
• W4294281861 hasRelatedWork W4220664568 @default.
• W4294281861 hasVolume "2022" @default.
• W4294281861 isParatext "false" @default.
• W4294281861 isRetracted "false" @default.
• W4294281861 workType "article" @default.